{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T19:27:52Z","timestamp":1758223672425,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.esmogo.2025.100227","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:22:14Z","timestamp":1756480934000},"page":"100227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience"],"prefix":"10.1016","volume":"9","author":[{"given":"M.","family":"Rimini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Presi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0517-911X","authenticated-orcid":false,"given":"K.","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.B.","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Raucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pedica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Foti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Camera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3142-483X","authenticated-orcid":false,"given":"M.","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7885-0636","authenticated-orcid":false,"given":"L.","family":"Passeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7280-1761","authenticated-orcid":false,"given":"G.","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Rossari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lo Prinzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Persano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-0935","authenticated-orcid":false,"given":"M.G.","family":"Cangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pecciarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.G.","family":"Arcidiacono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Falcinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Patricelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Casadei-Gardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.esmogo.2025.100227_bib1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1080\/17474124.2021.1991313","article-title":"Cholangiocarcinoma: new perspectives for new horizons","volume":"15","author":"Rimini","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100227_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100227_bib3","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1053\/j.gastro.2018.01.033","article-title":"Patterns and trends of liver cancer incidence rates in eastern and Southeastern Asian countries (1983-2007) and predictions to 2030","volume":"154","author":"Wu","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100227_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J Hepatol"},{"issue":"14","key":"10.1016\/j.esmogo.2025.100227_bib5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100227_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"issue":"suppl 4","key":"10.1016\/j.esmogo.2025.100227_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.2022.40.4_suppl.378","article-title":"A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1","volume":"40","author":"Oh","year":"2022","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.esmogo.2025.100227_bib8","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100227_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100227_bib10","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100227_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100227_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"issue":"57","key":"10.1016\/j.esmogo.2025.100227_bib13","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.18632\/oncotarget.27224","article-title":"Germline mutations in cancer-predisposition genes in patients with biliary tract cancer","volume":"10","author":"Terashima","year":"2019","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100227_bib14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations","volume":"68","author":"Wardell","year":"2018","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100227_bib15","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.32740","article-title":"Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings","volume":"126","author":"Maynard","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.esmogo.2025.100227_bib16","article-title":"Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer","volume":"12","author":"Yu","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100227_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","article-title":"Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer","volume":"78","author":"Okawa","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100227_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1158\/1940-6207.CAPR-21-0189","article-title":"Germline cancer susceptibility gene testing in unselected patients with hepatobiliary cancers: a multi-center prospective study","volume":"15","author":"Uson Junior","year":"2022","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100227_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100227_bib20","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/1097-0142(19891101)64:9<1971::AID-CNCR2820640935>3.0.CO;2-L","article-title":"Characteristics of familial colon cancer in a large population data base","volume":"64","author":"Cannon-Albright","year":"1989","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100227_bib21","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.1979.03300120022017","article-title":"Family history in an oncology clinic. Implications for cancer genetics","volume":"242","author":"Lynch","year":"1979","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100227_bib22","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1200\/JCO.1994.12.8.1724","article-title":"Quantitating familial cancer risk: a resource for clinical oncologists","volume":"12","author":"Offit","year":"1994","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100227_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oncolo\/oyac164","article-title":"Concordance between genomic alterations detected by tumor and germline sequencing: results from a tertiary care academic center molecular tumor board","volume":"28","author":"Green","year":"2023","journal-title":"Oncologist"},{"issue":"15","key":"10.1016\/j.esmogo.2025.100227_bib24","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients","volume":"37","author":"Kurian","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmogo.2025.100227_bib25","article-title":"Understanding the uptake and challenges of genetic testing guidelines for prostate cancer patients","volume":"32","author":"Suri","year":"2022","journal-title":"Cancer Treat Res Commun"},{"issue":"17","key":"10.1016\/j.esmogo.2025.100227_bib26","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.3390\/cancers13174259","article-title":"Targeting DNA damage repair mechanisms in pancreas cancer","volume":"13","author":"Perkhofer","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100227_bib27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ijc.30197","article-title":"Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH","volume":"139","author":"Win","year":"2016","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.esmogo.2025.100227_bib28","doi-asserted-by":"crossref","first-page":"E1861","DOI":"10.1002\/humu.21363","article-title":"Adenine DNA glycosylase activity of 14 human MutY homolog (MUTYH) variant proteins found in patients with colorectal polyposis and cancer","volume":"31","author":"Goto","year":"2010","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100227_bib29","article-title":"A case report of CHEK2 and MUTYH germline mutations associated with cholangiocarcinoma in a young patient","volume":"14","author":"Rehman","year":"2022","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100227_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100227_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10689-014-9699-2","article-title":"The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer","volume":"13","author":"Casper","year":"2014","journal-title":"Fam Cancer"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100227_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15586\/jkcvhl.v10i3.242","article-title":"Hereditary renal cell carcinoma: is age an independent criterion for genetic testing? A large cohort from a Latin America referral center","volume":"10","author":"Carminatti","year":"2023","journal-title":"J Kidney Cancer VHL"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100227_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10549-023-06946-8","article-title":"The association between age at breast cancer diagnosis and prevalence of pathogenic variants","volume":"199","author":"Daly","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100227_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100227_bib35","first-page":"1122","article-title":"NCCN Guidelines\u00ae Insights: Genetic\/Familial High-Risk Assessment: Colorectal, version 1.2021","volume":"19","author":"Weiss","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100227_bib36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/annonc\/mdz136","article-title":"Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group","volume":"30","author":"Mandelker","year":"2019","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100227_bib37","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41436-020-0783-8","article-title":"Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Li","year":"2020","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100227_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100526","article-title":"Discrepancies between tumor genomic profiling and germline genetic testing","volume":"7","author":"Pauley","year":"2022","journal-title":"ESMO Open"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100227_bib39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JOP.19.00201","article-title":"When should tumor genomic profiling prompt consideration of germline testing?","volume":"15","author":"DeLeonardis","year":"2019","journal-title":"J Oncol Pract"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100227_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19452","article-title":"Yield and utility of germline testing following tumor sequencing in patients with cancer","volume":"3","author":"Lincoln","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100227_bib41","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036590","article-title":"Tumor-based genetic testing and familial cancer risk","volume":"10","author":"Forman","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100227_bib42","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/path.5031","article-title":"The emerging significance of secondary germline testing in cancer genomics","volume":"244","author":"Mandelker","year":"2018","journal-title":"J Pathol"},{"issue":"4-5","key":"10.1016\/j.esmogo.2025.100227_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/17474124.2024.2337000","article-title":"Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art","volume":"18","author":"Rimini","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:01:44Z","timestamp":1758189704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819825000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S2949819825000962"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100227","relation":{},"ISSN":["2949-8198"],"issn-type":[{"type":"print","value":"2949-8198"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100227"}}